Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study
Title:
Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study
Author:
Strosberg, Jonathan Kunz, Pamela L. Hendifar, Andrew Yao, James Bushnell, David Kulke, Matthew H. Baum, Richard P. Caplin, Martyn Ruszniewski, Philippe Delpassand, Ebrahim Hobday, Timothy Verslype, Chris Benson, Al Srirajaskanthan, Rajaventhan Pavel, Marianne Mora, Jaume Berlin, Jordan Grande, Enrique Reed, Nicholas Seregni, Ettore Paganelli, Giovanni Severi, Stefano Morse, Michael Metz, David C. Ansquer, Catherine Courbon, Frédéric Al-Nahhas, Adil Baudin, Eric Giammarile, Francesco Taïeb, David Mittra, Erik Wolin, Edward O’Dorisio, Thomas M. Lebtahi, Rachida Deroose, Christophe M. Grana, Chiara M. Bodei, Lisa Öberg, Kjell Polack, Berna Degirmenci He, Beilei Mariani, Maurizio F. Gericke, Germo Santoro, Paola Erion, Jack L. Ravasi, Laura Krenning, Eric ,
Appeared in:
European journal of nuclear medicine and molecular imaging